Understanding ACOs & Emerging Delivery Market Influence to Drive Strategic Business Decisions

AJMC is proud to bring you an educational webinar that will tell how innovative data curation methods can provide well-informed, actionable business strategies for the evolving healthcare landscape.

Related Videos

Related Content

Advertisement

July 25th 2025

TP53 Mutations Remain Important Research Focus in Cancer

Jared Kaltwasser

TP53 mutations can have a significant impact on the prognosis of diseases like chronic lymphocytic leukemia, but their effect can vary based on numerous factors.

July 24th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

July 24th 2025

Addressing Acne in Patients of Color

Pearl Steinzor

Culturally informed, patient-centered strategies are needed to address acne and hyperpigmentation in patients with skin of color.

Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

July 24th 2025

FDA Approves Delgocitinib for Moderate to Severe Hand Eczema

Maggie L. Shaw

Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are contraindicated stand to benefit the most from this approval.

July 24th 2025

Ruxolitinib Cream Shows Long-Term AD Control in Children Ages 2 to 11

Pearl Steinzor

New data highlight efficacy, safety, and time off treatment with as-needed ruxolitinib cream in pediatric atopic dermatitis.

Related Content

Advertisement

July 25th 2025

TP53 Mutations Remain Important Research Focus in Cancer

Jared Kaltwasser

TP53 mutations can have a significant impact on the prognosis of diseases like chronic lymphocytic leukemia, but their effect can vary based on numerous factors.

July 24th 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

July 24th 2025

Addressing Acne in Patients of Color

Pearl Steinzor

Culturally informed, patient-centered strategies are needed to address acne and hyperpigmentation in patients with skin of color.

Published: July 15th 2025 | Updated: July 15th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

July 24th 2025

FDA Approves Delgocitinib for Moderate to Severe Hand Eczema

Maggie L. Shaw

Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are contraindicated stand to benefit the most from this approval.

July 24th 2025

Ruxolitinib Cream Shows Long-Term AD Control in Children Ages 2 to 11

Pearl Steinzor

New data highlight efficacy, safety, and time off treatment with as-needed ruxolitinib cream in pediatric atopic dermatitis.